Trial Profile
A Randomized, Single-Dose, Parallel Group, Comparative Pharmacokinetic (PK) Study to Evaluate Malathion Gel 0.5% Versus Ovide (Malathion) Lotion 0.5% in Patients With Pediculosis Capitis
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 24 Aug 2016
Price :
$35
*
At a glance
- Drugs Malathion (Primary)
- Indications Pediculosis
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Taro Pharmaceuticals USA
- 21 Oct 2014 New trial record